Voluntary Assisted Dying: An International Perspective on End of Life Choices for Cancer Patients (Paperback or Softback)

Board, Ruth E.

ISBN 10: 1739427025 / ISBN 13: 9781739427023

Published by Ebn Health 11/18/2025, 2025

About this Item

Voluntary Assisted Dying: An International Perspective on End of Life Choices for Cancer Patients.

Seller Inventory # BBS-9781739427023

Bibliographic Details

• Title: Voluntary Assisted Dying: An International Perspective on End of Life Choices for Cancer Patients (Paperback or Softback)
• Publisher: Ebn Health 11/18/2025
• Publication Date: 2025
• Language: English
• ISBN 10: 1739427025
• ISBN 13: 9781739427023
• Binding: Paperback or Softback
• Edition: 2nd Edition
• Condition: New
• Weight: 0.6 pounds
• Book Type: Book

About this title

Synopsis

This is a clear, balanced overview of international experience with Voluntary Assisted Dying (VAD). It draws on medical literature, government reports, and official data from around the world to help inform public and professional discussion. It updates work conducted and published in 2020 in the book End of Life Choices for Cancer Patients.

More than 280 million people live in countries where some form of assisted dying is legal. International evidence shows that with clear rules, strong safeguards, and professional support, VAD can be provided safely and respectfully. Across all jurisdictions, strong regulation, adequate resources, and professional training are essential. Continuous oversight and transparency remain crucial. Doctors, nurses, and allied professionals must have access to training, supervision, and the ability to opt out on grounds of conscience.

Assisted dying raises difficult moral and emotional issues for healthcare staff. Even in countries with long experience, many professionals find participation challenging. Some now specialise in VAD to manage the ethical and technical complexities. All agree that high-quality palliative care remains essential. Most patients who choose VAD have already received palliative care but want control over the timing and nature of death. Neurodegenerative diseases, such as motor neurone disease, need special planning because of the risk of losing mental or physical capacity before a decision can be acted on.

For countries like the UK who are deciding whether to change the law, much can be learned from decades of international experience and evidence - especially from Australia, New Zealand, Canada, the USA and parts of Europe - to design a system that protects vulnerable people, pays attention to the views and needs of disabled and disadvantaged people, respects those with ethical or religious objections, supports healthcare professionals, and respects individual choice.